These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 24992527)

  • 1. Urine miRNA in nephrotic syndrome.
    Szeto CC
    Clin Chim Acta; 2014 Sep; 436():308-13. PubMed ID: 24992527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary sediment miRNA levels in adult nephrotic syndrome.
    Wang G; Kwan BC; Lai FM; Chow KM; Li PK; Szeto CC
    Clin Chim Acta; 2013 Mar; 418():5-11. PubMed ID: 23313053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma microRNA-186 and proteinuria in focal segmental glomerulosclerosis.
    Zhang C; Zhang W; Chen HM; Liu C; Wu J; Shi S; Liu ZH
    Am J Kidney Dis; 2015 Feb; 65(2):223-32. PubMed ID: 25218681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNAs in IgA nephropathy.
    Szeto CC; Li PK
    Nat Rev Nephrol; 2014 May; 10(5):249-56. PubMed ID: 24709842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miRNAs in urine: a mirror image of kidney disease?
    Papadopoulos T; Belliere J; Bascands JL; Neau E; Klein J; Schanstra JP
    Expert Rev Mol Diagn; 2015 Mar; 15(3):361-74. PubMed ID: 25660955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary sediment ICAM-1 level in lupus nephritis.
    Guan J; Wang G; Tam LS; Kwan BC; Li EK; Chow KM; Li PK; Szeto CC
    Lupus; 2012 Oct; 21(11):1190-5. PubMed ID: 22685016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Micro-RNA expression in the urinary sediment of patients with chronic kidney diseases.
    Szeto CC; Ching-Ha KB; Ka-Bik L; Mac-Moune LF; Cheung-Lung CP; Gang W; Kai-Ming C; Kam-Tao LP
    Dis Markers; 2012; 33(3):137-44. PubMed ID: 22960330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary miRNA-27b-3p and miRNA-1228-3p correlate with the progression of Kidney Fibrosis in Diabetic Nephropathy.
    Conserva F; Barozzino M; Pesce F; Divella C; Oranger A; Papale M; Sallustio F; Simone S; Laviola L; Giorgino F; Gallone A; Pontrelli P; Gesualdo L
    Sci Rep; 2019 Aug; 9(1):11357. PubMed ID: 31388051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary miRNA profile for the diagnosis of IgA nephropathy.
    Szeto CC; Wang G; Ng JK; Kwan BC; Mac-Moune Lai F; Chow KM; Luk CC; Lai KB; Li PK
    BMC Nephrol; 2019 Mar; 20(1):77. PubMed ID: 30832601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review: The role of microRNAs in kidney disease.
    Li JY; Yong TY; Michael MZ; Gleadle JM
    Nephrology (Carlton); 2010 Sep; 15(6):599-608. PubMed ID: 20883280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary miR-21, miR-29, and miR-93: novel biomarkers of fibrosis.
    Wang G; Kwan BC; Lai FM; Chow KM; Li PK; Szeto CC
    Am J Nephrol; 2012; 36(5):412-8. PubMed ID: 23108026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of urinary miRNA biomarkers for detecting cisplatin-induced proximal tubular injury in rats.
    Kanki M; Moriguchi A; Sasaki D; Mitori H; Yamada A; Unami A; Miyamae Y
    Toxicology; 2014 Oct; 324():158-68. PubMed ID: 24863737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biomarker discovery in glomerular diseases using urinary proteomics.
    Thongboonkerd V
    Proteomics Clin Appl; 2008 Oct; 2(10-11):1413-21. PubMed ID: 21136790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum and urinary free microRNA level in patients with systemic lupus erythematosus.
    Wang G; Tam LS; Li EK; Kwan BC; Chow KM; Luk CC; Li PK; Szeto CC
    Lupus; 2011 Apr; 20(5):493-500. PubMed ID: 21372198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary microRNA in kidney disease: utility and roles.
    Sun IO; Lerman LO
    Am J Physiol Renal Physiol; 2019 May; 316(5):F785-F793. PubMed ID: 30759023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Study of the biopsied nephrotic syndrome for 20 years in the Cadiz Bay Area: histological correspondence, renal prognosis and clinical prognostic factors].
    Quirós PL; Ceballos M; Remón C; Lozano A; del Castillo R; Aznar E; Pérez Pérez-Ruilópez MA; Rivero M; Fernández Ruiz E
    Nefrologia; 2005; 25(2):147-54. PubMed ID: 15912651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Terminal complement complex (TCC) levels in urine in patients with renal diseases].
    Yasuda K
    Hokkaido Igaku Zasshi; 2001 Mar; 76(2):71-84. PubMed ID: 11344904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNAs and the kidney: coming of age.
    Saal S; Harvey SJ
    Curr Opin Nephrol Hypertens; 2009 Jul; 18(4):317-23. PubMed ID: 19424061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between urinary podocytes and kidney diseases.
    Sun D; Zhao X; Meng L
    Ren Fail; 2012; 34(3):403-7. PubMed ID: 22250862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dipping your feet in the water: podocytes in urine.
    Sir Elkhatim R; Li JY; Yong TY; Gleadle JM
    Expert Rev Mol Diagn; 2014 May; 14(4):423-37. PubMed ID: 24724555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.